Search Results for 'immunotherapy'
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
Oncorus to Build GMP Viral Immunotherapy Mfg. Facility
88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.Contract Pharma Staff 01.04.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
GEMoaB, Intellia Enter Cellular Immunotherapy Research Pact
Will combine GEMoaB's RevCAR technology platform with Intellia's genome editing technologies to discover and develop allogeneic cellular immunotherapies.Contract Pharma Staff 07.20.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
BioInvent, Pfizer Extend Immunotherapy Research Term
Allows the companies to further identify and characterize new targets and antibodies leveraging BioInvent's F.I.R.S.T drug discovery platform.Contract Pharma Staff 07.01.20
-
Breaking News | Industry News
Centogene Opening Lab to Increase COVID-19 Testing
Acquiring former laboratory facilities and equipment of Provecs Medical GmbH in Hamburg, GermanyContract Pharma Staff 04.15.20
-
CytoSorbents Gets EUA for Blood Purification Technology
CytoSorb can be used treat cytokine storm and deadly inflammation in critically-ill COVID-19 patientsContract Pharma Staff 04.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
GenScript ProBio, Eutilex Enter Cancer Collaboration
Partner on plasmid and virus process development and manufacturing for CAR-T programsContract Pharma Staff 04.09.20
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Coronavirus Consortium Accelerates Immunotherapy Research
To leverage Carterra’s LSA platform to screen hundreds of antibodies in a few days as CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks03.31.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Cobra Bio, Karolinska Inst. to Develop COVID-19 Vaccine
OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak03.30.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech Reports Progress on COVID-19 Vaccine Program
Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 202003.16.20
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
WindMIL Therapeutics and Cognate BioServices Enter Agreement
To expand MILs manufacturing capacity03.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CEL-SCI Developing Immunotherapy to Treat Coronavirus
Will leverage LEAPS peptide technology to reduce COVID-19 viral load and tissue damage resulting from infection in the lungs.03.09.20
-
Bora: Fast-growing CDMO Expands in U.S.
Contract Pharma talks with Samuel Ricchezza about the Taiwan-based CDMO’s push into North America.Tim Wright, Editor, Contract Pharma 03.04.20
-
-
Realizing the Full Potential of Precision Medicine in Oncology
Innovation in oncology drug development is being driven by “precision medicine"Peter Larson, Executive Medical Director, Hematology-Oncology, Premier Research 01.28.20
-
Biologics, Proteins, Vaccines
Biopharma Contract Manufacturing Pricing Analysis
Expect increased prices over the next two years, but at slightly lower than historical trendsWilliam Downey, HighTech Business Decisions 01.28.20
-
Bio News | Breaking News | Facilities | Fill/Finish | Industry News
Cognate Completes Cobra Acquisition
Cobra Biologics has cGMP facilities in the UK and Sweden.01.27.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Just - Evotec, OncoResponse Enter Antibody Alliance
Will leverage J.DESIGN to provide OncoResponse with services to accelerate OR2805 into the clinic01.16.20
-
Breaking News
Shimadzu, Providence Partner to Advance Immunotherapy Research
Developing technologies to identify cancer antigens.Shimadzu 01.14.20
-
Biologics, Proteins, Vaccines | Drug Development | Industry News
Avacta, Daewoong Form Immunotherapy JV
Aims to develop next generation cell and gene therapies incorporating Affimer proteins01.08.20
-
Breaking News | Collaborations & Alliances | Drug Development
Arena, Beacon Ink Strategic Immunotherapy Alliance
To develop promising compounds for a variety of immune and inflammatory diseases across a range of G protein-coupled receptor targets01.02.20
-
-
Breaking News | Drug Development | Industry News
Sanofi Acquires Synthorx in $2.5B Deal
CA-based immuno-oncology company expands Sanofi's cancer and autoimmune pipeline12.10.19
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Harpoon, Abbvie Expand Immunotherapy Alliance
New license and option agreement represents a potential transaction value of as much as $510 million11.21.19
-
Breaking News | Drug Development | Industry News
ABL Bio, GenScript Enter Bispecific Antibody Alliance
GenScript will serve as ABL Bio’s exclusive supplier of CDMO services for IND-enabling studies and clinical material manufacturing11.19.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
ABL Bio, GenScript Enter Biologics Partnership
ABL appoints GenScript as the exclusive supplier of CDMO services.11.18.19
-
Drug Development | Drug Discovery
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Cognate BioServices Acquires Cobra Biologics
Creates global cell and gene therapy manufacturing services platform for both clinical and commercial products.11.11.19
-
Breaking News | Collaborations & Alliances | Drug Development
Genentech Selects Affimed Target in Immunotherapy Alliance
Genentech is responsible for clinical development and commercialization worldwide11.08.19
-
-
Concentration and Reformulation of Cellular Immunotherapies – A Major Downstream Processing Step
...
-
cGMP Manufacture
Just in Time Manufacturing
Changing perceptions of Just in Time Manufacturing in a clinical supply environment.Natalie Balanovsky, Just in Time Manufacturing Solutions Manager, Almac Clinical Services 10.16.19
-
Breaking News | GMPs/GCPs | Industry News | Inspections
ASIT biotech Receives GMP Certification
Site in Liège, Belgium to manufacture in-house the active pharmaceutical ingredient of its leading product for grass pollen allergies10.07.19
-
Biologics, Proteins, Vaccines | Cold Chain Management | Drug Development | Supply Chain
CAR T for Large Tumors: The Next Frontier?
Ryan Carpentier of Cryoport discusses the successes and the challenges these exciting new therapies presentRyan Carpentier, Executive Director of Business Development at Cryoport 09.10.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
IRBM Signs Agreement with MD Anderson Cancer Center
To generate novel immune-checkpoint monoclonal antibodies09.10.19
-
-
Roche’s Tecentriq/Abraxane Combo for TNBC Approved by EU
The Tecentriq combination marks the first cancer immunotherapy regimen to be available in Europe for triple-negative breast cancer08.29.19
-
Vaccitech Appoints CEO
Bill Enright, former CEO at Gaithersburg-based Altimmune, brings experience in progressing science research, and development through executive and management roles08.27.19
-
Harbour BioMed, PPD to Develop Oncology and Immunology Therapeutics
Will focus on developing HBM4003, an anti-cancer immunotherapy to target solid tumors08.27.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Genprex Partner Aldevron Completes Step in Mfg. for Oncoprex Clinical Devt. Program
Newly manufactured plasmids will be used in clinical trials evaluating Oncoprex in combination with targeted therapies and immunotherapies08.09.19
-
-
-
-
-
-
Industry News | Supply Chain
Cobra Biologics and Symbiosis Complete Viral Vector Supply Chain
Develops capabilities intended to accelerate the clinical and commercial production of viral vectors06.25.19
-
Genocea’s GEN-009 Vaccine Achieves Positive Results
Post-vaccination T cell responses detected to 91% of vaccine neoantigens, including CD8+ T cell responses to 53% of vaccine neoantigens06.18.19
-
Drug Development
What I’m Looking Forward to at ASCO 2019
Erin Finot discusses the advances in science and oncology drug development at ASCOErin Finot, MS, MBA, Global Head of Immuno-Oncology, Oncology Division, IQVIA Biotech 05.28.19
-
Biologics, Proteins, Vaccines | Biosimilars
Are Biotech Companies Strong Investments?
Biotech capital raised via IPO has increased dramatically over the past couple of years.Jason Monteleone , CEO, Clinipace 05.07.19
-
Collaborations & Alliances | Drug Development
Bio-Techne, Elpiscience Enter Strategic Anti-Cancer Alliance
Elpiscience will have access to multiple antibodies from Bio-Techne's product portfolio for use in the development of biopharmaceuticals04.22.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Rexahn & BioSense Enter License Agreement
To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China04.16.19
